UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000024593
Receipt No. R000028292
Official scientific title of the study Examination of the effectiveness against retinal vascular occlusion treated with retinal endovascular surgery using tissue plasminogen activator.
Date of disclosure of the study information 2017/01/01
Last modified on 2016/10/27 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Examination of the effectiveness against retinal vascular occlusion treated with retinal endovascular surgery using tissue plasminogen activator.
Title of the study (Brief title) Examination of retinal endovascular surgery against retinal vascular occlusion.
Region
Japan

Condition
Condition retinal vein occlusion
retinal artery occlusion
Classification by specialty
Ophthalmology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate the efficacy and safety of the retinal endovascular therapy using tissue plasminogen activator against retinal vascular occlusion
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Postoperative week 1 : visual acuity, postoperative complication , Optical Coherence Tomography (OCT)
Postoperative week 4 : visual acuity, postoperative complication , OCT
Postoperative week 12 : visual acuity, postoperative complication , OCT
Postoperative week 24 : visual acuity, postoperative complication , OCT , fluorescein fundus angiography (FAG)
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 We inject tissue plasminogen activator (t-PA, a monteplase) 5000IU into a retinal vascular used in vitreous surgery.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria The patient undergoing vitreous surgery and stay in hospital for about one week in our hospital.
The patient receives a sufficient explanation about vitreous surgery. The patient who we can get a patient's informed consent before conducting the treatment.
Key exclusion criteria We take patient's past medical history. We exclude a patient with cerebrovascular disorders and patient with a history of cerebral infarction and blood disease.
And the case is judged to be at high risk to use t-PA for patients.
Target sample size 10

Research contact person
Name of lead principal investigator Chie Sotozono
Organization Kyoto Prefectual Univercity of Medicine
Division name Department of Ophthalmology
Address 465 Kajii cho Hirokoji agaru Kawaramachi dori Kamigyo ku Kyoto
TEL 075-251-5578
Email csotozon@koto.kpu-m.ac.jp

Public contact
Name of contact person Yoichiro Shinkai
Organization Kyoto Prefectual Univercity of Medicine
Division name Department of Ophthalmology
Address 465 Kajii cho Hirokoji agaru Kawaramachi dori Kamigyo ku Kyoto
TEL 075-251-5578
Homepage URL
Email yshinkai@koto.kpu-m.ac.jp

Sponsor
Institute Kyoto Prefectual Univercity of Medicine
Institute
Department

Funding Source
Organization the cost from Kyoto Prefectual Univercity of Medicine, Department of Ophthalmology
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 01 Month 01 Day

Progress
Recruitment status Preinitiation
Date of protocol fixation
2016 Year 11 Month 10 Day
Anticipated trial start date
2017 Year 01 Month 04 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2016 Year 10 Month 27 Day
Last modified on
2016 Year 10 Month 27 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028292